Antimicrobial and Anti-Biofilm Activity of Polymyxin E Alone and in Combination with Probiotic Strains of KATMIRA1933 and B-1895 Against Clinical Isolates of Selected Spp.: A Preliminary Study

Overview

Journal Pathogens

Date 2021 Dec 28

PMID 34959528

Citations 10

Authors

Munaf Al-Dulaimi

Ammar Algburi

Alyaa Abdelhameed

Maria S Mazanko

Dmitry V Rudoy

Alexey M Ermakov

Michael L Chikindas

Affiliations

Soon will be listed here.

Abstract

spp., the nosocomial pathogen, forms strong biofilms and is resistant to numerous antibiotics, causing persistent infections. This study investigates the antibacterial and anti-biofilm activity of polymyxin E alone and in combination with the cell-free supernatants (CFS) of the tested probiotic bacilli, KATMIRA1933 and B-1895 against the selected spp. starins. Three isolates of spp., designated as spp. isolate 1; spp. isolate 2, and spp. isolate 3, were collected from patients with burns, wounds, and blood infections, respectively. Bacterial identification and antibiotic susceptibility testing were conducted using the VITEK2 system. Auto-aggregation and coaggregation of the tested bacilli strains with the selected spp. isolates were evaluated. A disk diffusion assay was used to identify the microorganism's susceptibility to the selected antibiotics, alone and in combination with the CFS of the bacilli. The MIC and MBIC (minimum inhibitory and minimum biofilm inhibitory concentrations) of polymyxin E combined with bacilli CFS were determined. spp. isolates were (i) sensitive to polymyxin E, (ii) able to form a strong biofilm, and (iii) resistant to the tested antibiotics and the CFS of tested bacilli. Significant inhibition of biofilm formation was noticed when CFS of the tested bacilli were combined with polymyxin E. The bacilli CFS showed synergy with polymyxin E against planktonic cells and biofilms of the isolated pathogens.

Citing Articles

Investigating the antimicrobial and antibiofilm properties of marine halophilic Bacillus species against ESKAPE pathogens.

Murphy M, Culligan E, Murphy C Environ Microbiol Rep. 2024; 16(5):e70027.

PMID: 39446085 PMC: 11500616. DOI: 10.1111/1758-2229.70027.

Antagonistic Effects of 090104 on Respiratory Pathogens.

Ortiz Moyano R, Dentice Maidana S, Imamura Y, Elean M, Namai F, Suda Y Microorganisms. 2024; 12(7).

PMID: 39065064 PMC: 11278748. DOI: 10.3390/microorganisms12071295.

Probiotics for Aquaculture: Hope, Truth, and Reality.

Todorov S, Scafuro Lima J, Vazquez Bucheli J, Popov I, Tiwari S, Chikindas M Probiotics Antimicrob Proteins. 2024; 16(6):2007-2020.

PMID: 38801620 DOI: 10.1007/s12602-024-10290-8.

Lactobacillus acidophilus VB1 co-aggregates and inhibits biofilm formation of chronic otitis media-associated pathogens.

Algburi A, Jassim S, Popov I, Weeks R, Chikindas M Braz J Microbiol. 2024; 55(3):2581-2592.

PMID: 38789905 PMC: 11405553. DOI: 10.1007/s42770-024-01363-5.

: Harnessing Its Potential for Industrial, Medical, and Agricultural Applications-A Comprehensive Review.

Zalila-Kolsi I, Ben-Mahmoud A, Al-Barazie R Microorganisms. 2023; 11(9).

PMID: 37764059 PMC: 10536829. DOI: 10.3390/microorganisms11092215.

References

Algburi A, Alazzawi S, Al-Ezzy A, Weeks R, Chistyakov V, Chikindas M . Potential Probiotics Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 Co-Aggregate with Clinical Isolates of Proteus mirabilis and Prevent Biofilm Formation. Probiotics Antimicrob Proteins. 2020; 12(4):1471-1483. DOI: 10.1007/s12602-020-09631-0. View

Turovskiy Y, Chikindas M . Zinc Lactate and Sapindin Act Synergistically with Lactocin 160 Against Gardnerella vaginalis. Probiotics Antimicrob Proteins. 2011; 3(2):144-9. PMC: 3138622. DOI: 10.1007/s12602-011-9068-5. View

Ayoub Moubareck C, Hammoudi Halat D . Insights into : A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen. Antibiotics (Basel). 2020; 9(3). PMC: 7148516. DOI: 10.3390/antibiotics9030119. View

. EUCAST Definitive Document E.Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin Microbiol Infect. 2001; 6(9):503-8. DOI: 10.1046/j.1469-0691.2000.00149.x. View

Algburi A, Zhang Y, Weeks R, Comito N, Zehm S, Pinto J . Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens. Antimicrob Agents Chemother. 2017; 61(12). PMC: 5700334. DOI: 10.1128/AAC.00650-17. View

Martin-Aspas A, Guerrero-Sanchez F, Garcia-Colchero F, Rodriguez-Roca S, Giron-Gonzalez J . Differential characteristics of colonization and infection: risk factors, clinical picture, and mortality. Infect Drug Resist. 2018; 11:861-872. PMC: 5995284. DOI: 10.2147/IDR.S163944. View

Mathur H, Field D, Rea M, Cotter P, Hill C, Ross R . Fighting biofilms with lantibiotics and other groups of bacteriocins. NPJ Biofilms Microbiomes. 2018; 4:9. PMC: 5908865. DOI: 10.1038/s41522-018-0053-6. View

Sato Y, Unno Y, Ubagai T, Ono Y . Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation. PLoS One. 2018; 13(3):e0194556. PMC: 5858813. DOI: 10.1371/journal.pone.0194556. View

Maleki M, Sekawi Z, Soroush S, Azizi-Jalilian F, Asadollahi K, Mohammadi S . Phenotypic and genotypic characteristics of tetracycline resistant Acinetobacter baumannii isolates from nosocomial infections at Tehran hospitals. Iran J Basic Med Sci. 2014; 17(1):21-6. PMC: 3938882. View

10.

Karacaer F, Hamed I, Ozogul F, Glew R, Ozcengiz D . The function of probiotics on the treatment of ventilator-associated pneumonia (VAP): facts and gaps. J Med Microbiol. 2017; 66(9):1275-1285. DOI: 10.1099/jmm.0.000579. View

11.

Taitt C, Leski T, Stockelman M, Craft D, Zurawski D, Kirkup B . Antimicrobial resistance determinants in Acinetobacter baumannii isolates taken from military treatment facilities. Antimicrob Agents Chemother. 2013; 58(2):767-81. PMC: 3910874. DOI: 10.1128/AAC.01897-13. View

12.

Ledder R, Timperley A, Friswell M, Macfarlane S, McBain A . Coaggregation between and among human intestinal and oral bacteria. FEMS Microbiol Ecol. 2008; 66(3):630-6. DOI: 10.1111/j.1574-6941.2008.00525.x. View

13.

Nhu N, Riordan D, Nhu T, Thanh D, Thwaites G, Lan N . The induction and identification of novel Colistin resistance mutations in Acinetobacter baumannii and their implications. Sci Rep. 2016; 6:28291. PMC: 4916428. DOI: 10.1038/srep28291. View

14.

Raut S, Rijal K, Khatiwada S, Karna S, Khanal R, Adhikari J . Trend and Characteristics of Infections in Patients Attending Universal College of Medical Sciences, Bhairahawa, Western Nepal: A Longitudinal Study of 2018. Infect Drug Resist. 2020; 13:1631-1641. PMC: 7293404. DOI: 10.2147/IDR.S257851. View

15.

Pfalzgraff A, Brandenburg K, Weindl G . Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds. Front Pharmacol. 2018; 9:281. PMC: 5882822. DOI: 10.3389/fphar.2018.00281. View

16.

Bahador A, Raoo An R, Farshadzadeh Z, Beitollahi L, Khaledi A, Rahimi S . The Prevalence of IS Aba 1 and IS Aba 4 in Acinetobacter baumannii Species of Different International Clone Lineages Among Patients With Burning in Tehran, Iran. Jundishapur J Microbiol. 2015; 8(7):e17167. PMC: 4575776. DOI: 10.5812/jjm.17167v2. View

17.

Asif M, Alvi I, Rehman S . Insight into : pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Resist. 2018; 11:1249-1260. PMC: 6110297. DOI: 10.2147/IDR.S166750. View

18.

Farshadzadeh Z, Taheri B, Rahimi S, Shoja S, Pourhajibagher M, Haghighi M . Growth Rate and Biofilm Formation Ability of Clinical and Laboratory-Evolved Colistin-Resistant Strains of . Front Microbiol. 2018; 9:153. PMC: 5816052. DOI: 10.3389/fmicb.2018.00153. View

19.

Eze E, Chenia H, El Zowalaty M . biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist. 2018; 11:2277-2299. PMC: 6245380. DOI: 10.2147/IDR.S169894. View

20.

Chapot-Chartier M, Kulakauskas S . Cell wall structure and function in lactic acid bacteria. Microb Cell Fact. 2014; 13 Suppl 1:S9. PMC: 4155827. DOI: 10.1186/1475-2859-13-S1-S9. View